Global Influenza Rapid Diagnostic Test Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Influenza Rapid Diagnostic Test market size will reach 1,219.48 Million USD in 2025 and is projected to reach 2,332.91 Million USD by 2032, with a CAGR of 9.71% (2025-2032). Notably, the China Influenza Rapid Diagnostic Test market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
An Influenza Rapid Diagnostic Test (RIDT) is a diagnostic tool designed for the quick and on-the-spot detection of the influenza virus. These tests are commonly used in healthcare settings, allowing for rapid results and timely decision-making in the management of influenza cases. RIDTs work by detecting specific viral antigens present in respiratory specimens such as nasal swabs or throat swabs. The procedure usually involves combining the patient＇s specimen with antibodies that can bind to influenza virus antigens. If the virus is present, a visible reaction occurs, indicating a positive result. Influenza RIDTs are valued for their speed and simplicity, providing results within minutes, which is especially beneficial for prompt clinical decision-making during flu seasons or outbreaks. While RIDTs are convenient for quick screening, more comprehensive diagnostic methods like molecular testing may be employed for confirmation and in cases where higher sensitivity and specificity are required.
The major global suppliers of Influenza Rapid Diagnostic Test include BD, Abbot (Alere), Quidel, Roche, Thermo Fisher Scientific, Meridian Bioscience, Analytik Jena, Princeton BioMeditech Corporation, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific, DiaSorin (Focus Diagnostics), Wondfo, Beijing Wantai Biological Pharmacy, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Influenza Rapid Diagnostic Test. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Influenza Rapid Diagnostic Test market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Influenza Rapid Diagnostic Test market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Influenza Rapid Diagnostic Test industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Influenza Rapid Diagnostic Test Include:
BD
Abbot (Alere)
Quidel
Roche
Thermo Fisher Scientific
Meridian Bioscience
Analytik Jena
Princeton BioMeditech Corporation
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
DiaSorin (Focus Diagnostics)
Wondfo
Beijing Wantai Biological Pharmacy
Influenza Rapid Diagnostic Test Product Segment Include:
Digital RIDTs
Conventional RIDT
Influenza Rapid Diagnostic Test Product Application Include:
Hospitals
POCT
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Influenza Rapid Diagnostic Test Industry PESTEL Analysis
Chapter 3: Global Influenza Rapid Diagnostic Test Industry Porter's Five Forces Analysis
Chapter 4: Global Influenza Rapid Diagnostic Test Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Influenza Rapid Diagnostic Test Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Influenza Rapid Diagnostic Test Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Influenza Rapid Diagnostic Test Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Influenza Rapid Diagnostic Test market size will reach 1,219.48 Million USD in 2025 and is projected to reach 2,332.91 Million USD by 2032, with a CAGR of 9.71% (2025-2032). Notably, the China Influenza Rapid Diagnostic Test market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
An Influenza Rapid Diagnostic Test (RIDT) is a diagnostic tool designed for the quick and on-the-spot detection of the influenza virus. These tests are commonly used in healthcare settings, allowing for rapid results and timely decision-making in the management of influenza cases. RIDTs work by detecting specific viral antigens present in respiratory specimens such as nasal swabs or throat swabs. The procedure usually involves combining the patient＇s specimen with antibodies that can bind to influenza virus antigens. If the virus is present, a visible reaction occurs, indicating a positive result. Influenza RIDTs are valued for their speed and simplicity, providing results within minutes, which is especially beneficial for prompt clinical decision-making during flu seasons or outbreaks. While RIDTs are convenient for quick screening, more comprehensive diagnostic methods like molecular testing may be employed for confirmation and in cases where higher sensitivity and specificity are required.
The major global suppliers of Influenza Rapid Diagnostic Test include BD, Abbot (Alere), Quidel, Roche, Thermo Fisher Scientific, Meridian Bioscience, Analytik Jena, Princeton BioMeditech Corporation, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific, DiaSorin (Focus Diagnostics), Wondfo, Beijing Wantai Biological Pharmacy, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Influenza Rapid Diagnostic Test. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Influenza Rapid Diagnostic Test market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Influenza Rapid Diagnostic Test market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Influenza Rapid Diagnostic Test industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Influenza Rapid Diagnostic Test Include:
BD
Abbot (Alere)
Quidel
Roche
Thermo Fisher Scientific
Meridian Bioscience
Analytik Jena
Princeton BioMeditech Corporation
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
DiaSorin (Focus Diagnostics)
Wondfo
Beijing Wantai Biological Pharmacy
Influenza Rapid Diagnostic Test Product Segment Include:
Digital RIDTs
Conventional RIDT
Influenza Rapid Diagnostic Test Product Application Include:
Hospitals
POCT
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Influenza Rapid Diagnostic Test Industry PESTEL Analysis
Chapter 3: Global Influenza Rapid Diagnostic Test Industry Porter's Five Forces Analysis
Chapter 4: Global Influenza Rapid Diagnostic Test Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Influenza Rapid Diagnostic Test Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Influenza Rapid Diagnostic Test Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Influenza Rapid Diagnostic Test Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Influenza Rapid Diagnostic Test Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Influenza Rapid Diagnostic Test Product by Type
- 1.2.1 Digital RIDTs
- 1.2.2 Conventional RIDT
- 1.3 Influenza Rapid Diagnostic Test Product by Application
- 1.3.1 Hospitals
- 1.3.2 POCT
- 1.3.3 Others
- 1.4 Global Influenza Rapid Diagnostic Test Market Size Analysis (2020-2032)
- 1.5 Influenza Rapid Diagnostic Test Market Development Status and Trends
- 1.5.1 Influenza Rapid Diagnostic Test Industry Development Status Analysis
- 1.5.2 Influenza Rapid Diagnostic Test Industry Development Trends Analysis
- 2 Influenza Rapid Diagnostic Test Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Influenza Rapid Diagnostic Test Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Influenza Rapid Diagnostic Test Market Analysis by Country
- 4.1 Global Influenza Rapid Diagnostic Test Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Influenza Rapid Diagnostic Test Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Influenza Rapid Diagnostic Test Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Influenza Rapid Diagnostic Test Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Influenza Rapid Diagnostic Test Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Influenza Rapid Diagnostic Test Market Revenue and Growth Rate (2020-2032)
- 4.5 China Influenza Rapid Diagnostic Test Market Revenue and Growth Rate (2020-2032)
- 4.6 France Influenza Rapid Diagnostic Test Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Influenza Rapid Diagnostic Test Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Influenza Rapid Diagnostic Test Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Influenza Rapid Diagnostic Test Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Influenza Rapid Diagnostic Test Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Influenza Rapid Diagnostic Test Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Influenza Rapid Diagnostic Test Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Influenza Rapid Diagnostic Test Market Revenue and Growth Rate (2020-2032)
- 4.14 India Influenza Rapid Diagnostic Test Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Influenza Rapid Diagnostic Test Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Influenza Rapid Diagnostic Test Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Influenza Rapid Diagnostic Test Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Influenza Rapid Diagnostic Test Market Revenue by Key Suppliers (2021-2025)
- 5.2 Global Influenza Rapid Diagnostic Test Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Influenza Rapid Diagnostic Test Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Influenza Rapid Diagnostic Test Market Analysis by Type
- 6.1 Global Influenza Rapid Diagnostic Test Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Influenza Rapid Diagnostic Test Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 BD
- 7.1.1 BD Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 BD Influenza Rapid Diagnostic Test Product Portfolio
- 7.1.3 BD Influenza Rapid Diagnostic Test Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Abbot (Alere)
- 7.2.1 Abbot (Alere) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Abbot (Alere) Influenza Rapid Diagnostic Test Product Portfolio
- 7.2.3 Abbot (Alere) Influenza Rapid Diagnostic Test Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Quidel
- 7.3.1 Quidel Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Quidel Influenza Rapid Diagnostic Test Product Portfolio
- 7.3.3 Quidel Influenza Rapid Diagnostic Test Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Roche
- 7.4.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Roche Influenza Rapid Diagnostic Test Product Portfolio
- 7.4.3 Roche Influenza Rapid Diagnostic Test Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Thermo Fisher Scientific
- 7.5.1 Thermo Fisher Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Thermo Fisher Scientific Influenza Rapid Diagnostic Test Product Portfolio
- 7.5.3 Thermo Fisher Scientific Influenza Rapid Diagnostic Test Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Meridian Bioscience
- 7.6.1 Meridian Bioscience Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Meridian Bioscience Influenza Rapid Diagnostic Test Product Portfolio
- 7.6.3 Meridian Bioscience Influenza Rapid Diagnostic Test Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Analytik Jena
- 7.7.1 Analytik Jena Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Analytik Jena Influenza Rapid Diagnostic Test Product Portfolio
- 7.7.3 Analytik Jena Influenza Rapid Diagnostic Test Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Princeton BioMeditech Corporation
- 7.8.1 Princeton BioMeditech Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Princeton BioMeditech Corporation Influenza Rapid Diagnostic Test Product Portfolio
- 7.8.3 Princeton BioMeditech Corporation Influenza Rapid Diagnostic Test Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 BioMerieux
- 7.9.1 BioMerieux Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 BioMerieux Influenza Rapid Diagnostic Test Product Portfolio
- 7.9.3 BioMerieux Influenza Rapid Diagnostic Test Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Sekisui Diagnostics
- 7.10.1 Sekisui Diagnostics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Sekisui Diagnostics Influenza Rapid Diagnostic Test Product Portfolio
- 7.10.3 Sekisui Diagnostics Influenza Rapid Diagnostic Test Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Response Biomedical
- 7.11.1 Response Biomedical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Response Biomedical Influenza Rapid Diagnostic Test Product Portfolio
- 7.11.3 Response Biomedical Influenza Rapid Diagnostic Test Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 SA Scientific
- 7.12.1 SA Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 SA Scientific Influenza Rapid Diagnostic Test Product Portfolio
- 7.12.3 SA Scientific Influenza Rapid Diagnostic Test Market Data Analysis (Revenue, Gross Ma
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
